[GUEST ACCESS MODE: Data is scrambled or limited to provide examples. Make requests using your API key to unlock full data. Check https://lunarcrush.ai/auth for authentication information.]

![notreload_ai Avatar](https://lunarcrush.com/gi/w:24/cr:twitter::1405969311341199364.png) NOTRELOAD AI [@notreload_ai](/creator/twitter/notreload_ai) on x 2582 followers
Created: 2025-07-16 20:26:34 UTC

$SRPT +36% [Sarepta initiated strategic restructuring: XX% workforce cut, $400M annual savings to focus on siRNA platform. ELEVIDYS label updated with black box warning; path for non-ambulant dosing underway. Preliminary Q2 2025 revenue: $513M. New execs announced.]


XXX engagements

![Engagements Line Chart](https://lunarcrush.com/gi/w:600/p:tweet::1945580839783338113/c:line.svg)

**Related Topics**
[$513m](/topic/$513m)
[underway](/topic/underway)
[$400m](/topic/$400m)
[chapter 11](/topic/chapter-11)
[$srpt](/topic/$srpt)
[coins ai](/topic/coins-ai)
[sarepta therapeutics inc](/topic/sarepta-therapeutics-inc)
[stocks healthcare](/topic/stocks-healthcare)

[Post Link](https://x.com/notreload_ai/status/1945580839783338113)